生物
突变体
食管
PI3K/AKT/mTOR通路
突变
转基因
细胞生长
细胞生物学
癌症研究
体内
细胞
基因
信号转导
遗传学
解剖
作者
Albert Herms,Bartomeu Colom,Gabriel Piedrafita,Argyro Kalogeropoulou,Ujjwal Banerjee,Charlotte King,Emilie Abby,Kasumi Murai,Irene Caseda,David Fernández‐Antorán,Swee Hoe Ong,Michael Hall,Christopher Bryant,Roshan Sood,Joanna C. Fowler,Albert Pol,Christian Frezza,Bart Vanhaesebroeck,Philip H. Jones
标识
DOI:10.1038/s41588-024-01891-8
摘要
Abstract Oncogenic PIK3CA mutations generate large clones in aging human esophagus. Here we investigate the behavior of Pik3ca mutant clones in the normal esophageal epithelium of transgenic mice. Expression of a heterozygous Pik3ca H1047R mutation drives clonal expansion by tilting cell fate toward proliferation. CRISPR screening and inhibitor treatment of primary esophageal keratinocytes confirmed the PI3K–mTOR pathway increased mutant cell competitive fitness. The antidiabetic drug metformin reduced mutant cell advantage in vivo and in vitro. Conversely, metabolic conditions such as type 1 diabetes or diet-induced obesity enhanced the competitive fitness of Pik3ca H1047R cells. Consistently, we found a higher density of PIK3CA gain-of-function mutations in the esophagus of individuals with high body mass index compared with those with normal weight. We conclude that the metabolic environment selectively influences the evolution of the normal epithelial mutational landscape. Clinically feasible interventions to even out signaling imbalances between wild-type and mutant cells may limit the expansion of oncogenic mutants in normal tissues.
科研通智能强力驱动
Strongly Powered by AbleSci AI